Analyzing Ratios: Design Therapeutics Inc (DSGN)’s Financial Story Unveiled

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 61516.0 shares were traded. DSGN stock price reached its highest trading level at $6.29 during the session, while it also had its lowest trading level at $6.07.

Ratios:

We take a closer look at DSGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 34.61 and its Current Ratio is at 34.61. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May 07, 2024, Upgraded its rating to Overweight and sets its target price to $12 from $6 previously.

On November 14, 2023, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $42 to $6.

Wedbush Downgraded its Outperform to Neutral on August 15, 2023, whereas the target price for the stock was revised from $19 to $6.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 18 ’24 when Prasad Deepa sold 3,806 shares for $6.27 per share. The transaction valued at 23,864 led to the insider holds 20,000 shares of the business.

William Arsani sold 814,874 shares of DSGN for $3,463,214 on Aug 09 ’24. The Director now owns 0 shares after completing the transaction at $4.25 per share. On Aug 09 ’24, another insider, Logos SPV 1 LP, who serves as the Director of the company, bought 814,874 shares for $4.24 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DSGN now has a Market Capitalization of 349351584 and an Enterprise Value of 97799800.

Stock Price History:

Over the past 52 weeks, DSGN has reached a high of $7.77, while it has fallen to a 52-week low of $2.24. The 50-Day Moving Average of the stock is 3.18%, while the 200-Day Moving Average is calculated to be 30.27%.

Shares Statistics:

According to the various share statistics, DSGN traded on average about 174.57K shares per day over the past 3-months and 226460 shares per day over the past 10 days. A total of 56.62M shares are outstanding, with a floating share count of 31.41M. Insiders hold about 44.52% of the company’s shares, while institutions hold 41.80% stake in the company. Shares short for DSGN as of 1734048000 were 2698771 with a Short Ratio of 15.46, compared to 1731628800 on 2691986. Therefore, it implies a Short% of Shares Outstanding of 2698771 and a Short% of Float of 10.560001.

Most Popular